Korean Chinese Japanese
  • Economy
  • Politics
  • Society
  • Securities
  • Real estate
  • Culture
  • Entertainment
  • Sports
  • Opinion
Korean Chinese Japanese
Economy Corporation Pharma & Bio
Society Politics IT·Science
Securities Real Estate Global
Opinion Entertainment Sports Culture
Video Auto in Golf in
PHARM EDAILY Market in TheBeLT
Pharma & Bio
Technology

Cha Healthcare’s Merger with ChaCares Ahead of Its IPO… What About Cha Kwang-ryeol and Cha Won-tae’s Stakes? [ChaBio Deep Dive ③]

The merger between Cha Healthcare and Cha Care, which the Cha Bio Group has been pursuing since late 2024, is closely tied to the ownership structure of the founding family. This is because Cha Kwang-…
  • 2026-10-26 07:01:02
  • KIM SAE-MI
Lifestyle

“Wasn’t Moderna the one that provided the cancer vaccine?”…Domestic treatment to prevent cancer recurrence

A “cancer vaccine” craze is sweeping the global anticancer drug market. This follows Moderna’s demonstration that its personalized mRNA cancer vaccine has the potential to suppress cancer recurrence. …
  • 2026-10-26 06:01:02
  • KIM JI-WAN
Business·Industry

[ESMO 2026] SillaJen, Inc.: “BAL0891 Demonstrates Disease Control in All Treatment Groups, Both as Monotherapy and in Combination… Complete Response Also Confirmed”

“Bladder cancer patients treated with BAL0891 have maintained treatment for over 18 months and have sustained a response for more than seven months even after achieving complete remission (CR).” Le…
  • 2026-10-25 12:01:02
  • Kim Jinsoo
Technology

Baeksite’s ‘31A’ Phase 3 Success… Competition Heats Up Ahead of SK Basa’s ‘21A’ Launch

With Baeksite successfully completing Phase 3 clinical trials for its pneumococcal vaccine “VAX-31” in adults, competition in the pneumococcal vaccine market appears to be intensifying. The vaccine fo…
  • 2026-10-25 06:41:02
  • KIM SUNG-JIN
Technology

Rokit Healthcare Plunges 20% Following FDA Warning Letter to U.S. Partner [K-bio Pulse]

Korean small-cap pharma, biotech, and healthcare stocks moved in opposite directions on Oct. 22, as large-cap chipmakers weakened. Rokit Healthcare posted the steepest decline on the KOSDAQ, while in-…
  • 2026-10-24 06:17:02
  • Kim Seung-kwon
Technology

ROKIT HEALTHCARE Inc. Plummets 20% Amid Fallout from U.S. Partner’s FDA Warning Letter [Bio Spotlight]

On the 22nd, while large-cap semiconductor stocks were weak on the domestic stock market, small- and mid-cap pharmaceutical, biotech, and healthcare stocks showed mixed performance. Among the top decl…
  • 2026-10-24 06:16:02
  • Kim Seung-kwon
Technology

Lemon Hits Limit-Up; Licensing Hopes Boost G2G and OliX [K-Bio Pulse]

South Korean biotech stocks posted strong gains on October 21, with Lemon Healthcare hitting the daily upper price limit despite no clear catalyst. G2GBIO surged on expectations of a potential licensi…
  • 2026-10-23 13:02:02
  • KIM SAE-MI
Technology

Lemon Healthcare Goes Public… Expectations Rise for Technology Exports to Big Pharma by G2GBIO, Inc. and Olix Pharmaceuticals, Inc. [Bio Spotlight]

On the 21st, in the biotech and healthcare sector, #LemonHealthcare hit the daily price limit, while #G2GBIO, Inc. surged on speculation about a potential technology transfer deal with Novo Nordisk. O…
  • 2026-10-23 13:01:02
  • KIM SAE-MI
Lifestyle

Is the Efficacy Announcement a “Predetermined Outcome”?… “Some Indicators Point in the Desired Direction”

Aptabio Therapeutics Inc.(293780)has expressed confidence ahead of the announcement of the efficacy of its kidney disease treatment candidate “Isuzinaxib” (APX-115). This follows the company’s selecti…
  • 2026-10-23 12:02:02
  • KIM JI-WAN
Lifestyle

Dop’s New Venture into Aesthetic Medicine Proves a ‘Huge Success’... Begins in Singapore and Begins Full-Scale Export Operations

DOP, a human tissue-based biotech company, is achieving remarkable results in the aesthetic medicine sector, a new market it has recently entered. “ESSALIA,” an injectable product based on acellular a…
  • 2026-10-23 09:31:02
  • YU JIN-HEE
prev 11 12 13 14 15 16 17 18 19 20 next

PHARM EDAILY

Shorts

EDAILY
  • 92, Tongil-ro, Jung-gu, Seoul, Korea
  • +82 2 3772 0114
  • webmaster@edaily.co.kr

※ This article has been translated using AI technology for the convenience of readers.

EDAILY provides this translation on an “as is” basis and makes no warranties, express or implied, regarding its accuracy, reliability, completeness, merchantability, or fitness for a particular purpose.
Due to the limitations of machine translation, the translated content may differ from the original Korean article. In the event of any discrepancy, the original Korean version shall prevail.
EDAILY shall not be liable for any loss or damage arising from the use of, or reliance on, the translated content.

© 2026 Copyrights by edaily. All Rights Reserved.
Korea China Japan
English